Evidence map›Paper›PMID 42877578›Full record

ReviewFrontiers in immunology2026

From scavenger to victim: mechanism and treatment of microglial ferroptosis in white matter injury disease.

Ruoyu Wang, Qiong Yang, Zheng Cao, Jianjie Zhou, Bingxin Tian, Xin Wang, Xiaohong Zhang, Qingwei Xiang, Gang Chen

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruoyu Wang *School of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
Qiong Yang *The First Clinical Medical School, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
Zheng CaoHubei Shizhen Laboratory Department of Geriatrics & Department of Orthopedic Surgery, Wuhan, Hubei, China.
Jianjie ZhouDepartment of Geriatrics, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.
Bingxin TianThe First Clinical Medical School, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
Xin WangThe First People's Hospital of Jingzhou (Jingzhou First People's Hospital), Jingzhou, Hubei, China.
Xiaohong ZhangXiangyang Hospital of Integrated Traditional Chinese and Western Medicine, Xiangyang, Hubei, China.
Qingwei XiangDepartment of Geriatrics, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.
Gang ChenHubei Shizhen Laboratory Department of Geriatrics & Department of Orthopedic Surgery, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Failure of myelin repair is a shared pathological feature of white matter injury (WMI)-associated diseases, including Alzheimer's disease (AD), vascular dementia (VaD), and multiple sclerosis (MS), but the underlying mechanisms remain incompletely understood. Microglia, the resident innate immune cells of the central nervous system (CNS), contribute to white matter homeostasis by clearing myelin debris and supporting remyelination. Within the iron- and lipid-rich white matter microenvironment, sustained uptake of myelin and oligodendroglial debris may impose phagocytic and metabolic stress on microglia, thereby increasing their susceptibility to ferroptosis, an iron-dependent form of regulated cell death driven by membrane phospholipid peroxidation. This susceptibility is regulated by interconnected mechanisms involving ferritinophagy-associated iron dysregulation, ACSL4/NOX2/15-LOX-related lipid peroxidation, and impaired endogenous ferroptosis-defense systems. Microglial responses are also heterogeneous: disease-associated, demyelination-associated, white matter-associated, lipid-droplet-accumulating, and degenerative microglial programs represent partially overlapping and context-dependent states rather than a proven linear trajectory. In susceptible microglial subsets, ferroptosis or ferroptosis-associated dysfunction may impair debris clearance and trophic support while promoting oxidized lipid accumulation and inflammatory signaling, thereby limiting remyelination. This review summarizes current evidence on the molecular mechanisms, multicellular interactions, microglial states, disease contexts, and therapeutic strategies associated with microglial ferroptosis in WMI. We further propose a functional therapeutic-window framework based on phagocytic competence, iron-lipid handling capacity, antioxidant reserve, and evidence of ferroptotic injury, and discuss major challenges in clinical translation. Overall, current evidence supports microglial ferroptosis as a context-dependent contributor to myelin repair failure rather than a universal determinant.

Indexed as

FerroptosisLeukoencephalopathiesMicrogliaWhite MatterAnimalsHumansIronLipid PeroxidationMyelin SheathIronAlzheimer’s diseaseferroptosismetabolic reprogrammingmicrogliamultiple sclerosisphagocytic overloadvascular dementiawhite matter injury

Identifiers

PMID42877578
PMCPMC13662909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.